Zinc sulfate Consumption In Premenstrual Syndrome: Measuring Its Effects on Quality of Life Using the PSST& SF12 Questionnairs

Phase 2

• Conditions: Premenstrual Syndrome.; Premenstrual tension syndrome

• Registration Number: IRCT138809232852N1
• Lead Sponsor: Tarbiat Modares Univresity

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 130

Inclusion Criteria

Inclusion criteria were: being single, suffering from moderate to severe PMS based on PSST questionnaires, age between 20 and 35 year with regular and normal menstruation (menstrual cycle 22 to 35 days and duration of bleeding 3 to 7 days), Normal BMI (26-19) Exclusion criteria: cardiovascular, pulmonary, renal, diabetes, liver, gastrointestinal, gynecological, and thromboembolic diseases, including chronic migraines, mental illness, taking any medication, and being under severe stress such as death of loved ones etc in the past three months, smoking and alcohol consumption, and consuming too much or too little food based on the questionnaire 1

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of Premenstrual Syndrome. Timepoint: Before intervention, the first month, second month and third month after the intervention. Method of measurement: Psst Questionnaire.;Quality of life. Timepoint: Before intervention, the first month, second month and third month. Method of measurement: sf12 Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Side effects, including gastrointestinal. Timepoint: After 3 month. Method of measurement: Questionnaire.;Tendency for future medication use. Timepoint: After 3 month. Method of measurement: Questionnaire.;Dysmenorrhea. Timepoint: After 3 month. Method of measurement: Questionnaire.